Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE

Fujifilm to spend $1.6B to bolster cell culture manufacturing services

By Brian Buntz | June 29, 2022

Fujifilm Diosynth TechnologiesThe multinational conglomerate Fujifilm will invest $1.6 billion to improve and ramp up the cell culture manufacturing services of its CDMO subsidiary Fujifilm Diosynth Biotechnologies.

Most of the investment will focus on a site in Hillerød, Denmark. A site in College Station, Texas, will also benefit from a funding injection.

The investment will increase the capacity of its cGMP batch manufacturing with the addition of eight 20,000L bioreactors and two downstream processing streams.

Fujifilm boasts that the Hillerød facility will be the largest end-to-end CDMO in Europe with 20 x 20,000L bioreactors for drug substance production.

The Denmark facility will also have sustainable production features. For example, it will use an electric boiler rather than one powered by natural gas. Fujifilm Diosynth Biotechnologies also will invest in technologies to curb water consumption.

Fujifilm expects the investment to create roughly 450 jobs. There are already 1,055 employees who work at the Hillerød site.

“Fujifilm is further expanding its bio CDMO business with the growth strategy of both capital investment and technological innovation to fulfill rapidly growing demand for high volume production of biopharmaceuticals,” said Teiichi Goto, president and CEO, representative director of Fujifilm Corp., in a statement “With this major investment in the large-scale production facility and the deployment of the next-generation production technology, we will be the best partner for customers as the premier bio CDMO. Fujifilm will, through creation of new value from innovation, contribute to the stable supply of high-quality biopharmaceuticals and to promoting a healthy society and further growth of healthcare industry.”

Fujifilm purchased the Hillerød site from Biogen in August 2019.

Over the past few years, Fujifilm has invested more than $7.1 billion to expand its CDMO business.

Fujifilm’s healthcare business unit has become the company’s largest segment in terms of revenue and operating income.

 

About The Author

Brian Buntz

The pharma and biotech editor of WTWH Media, Brian is a veteran journalist with more than 15 years of experience covering an array of life science topics, including clinical trials, drug discovery and development and medical devices. Before coming to WTWH, he served as content director focused on connected devices at Informa. In addition, Brian covered the medical device sector for 10 years at UBM. At Qmed, he overhauled the brand’s news coverage and helped to grow the site’s traffic volume dramatically. He had previously held managing editor roles on two of the company’s medical device technology publications. Connect with him on LinkedIn or email at bbuntz@wtwhmedia.com.

Tell Us What You Think! Cancel reply

Related Articles Read More >

Moving toward the autonomous lab and what’s possible today
Antheia_Logo (1)
Pharma ingredient manufacturer Antheia raises $56M Series C
Genentech roche
Roche, Genentech to build $700M drug manufacturing plant in North Carolina
These are the logos of Otsuka Medical and ICU Medical.
ICU Medical, Otsuka Pharmaceutical Factory launch joint IV supply chain venture
“ppw
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news, technologies, and developments in Pharmaceutical Processing.

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Pharmaceutical Processing World
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index
  • R&D 100 Awards

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE